ArticleFrontiers in pharmacology2021

What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China.

Shimeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.